Cargando…

A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia

STUDY OBJECTIVE: Multimorbidity and multimedicine use are common in people with cardiovascular disease and can lead to harms, such as prescribing errors and drug interactions. We quantified multimedicine use in people treated with cardiovascular medicines in a national sample of Australians. DESIGN:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaffer, Andrea L., Chia, Joel, Brett, Jonathan, Pearson, Sallie‐Anne, Falster, Michael O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828398/ https://www.ncbi.nlm.nih.gov/pubmed/36239072 http://dx.doi.org/10.1002/phar.2735

Ejemplares similares

Persistence and Adherence to Cardiovascular Medicines in Australia
por: de Oliveira Costa, Juliana, et al.
Publicado: (2023)

Ginkgo biloba: A Treasure of Functional Phytochemicals with Multimedicinal Applications
por: Noor-E-Tabassum,, et al.
Publicado: (2022)

Papaverine: A Miraculous Alkaloid from Opium and Its Multimedicinal Application
por: Ashrafi, Sania, et al.
Publicado: (2023)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Evidence‐practice gaps in P2Y(12) inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population‐level data linkage in Australia
por: Falster, Michael O., et al.
Publicado: (2022)

The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians
por: Pearson, Sallie-Anne, et al.
Publicado: (2014)

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
por: Tang, Monica, et al.
Publicado: (2021)

Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC)
por: Daniels, Benjamin, et al.
Publicado: (2017)

Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)
por: Lin, Jialing, et al.
Publicado: (2023)

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children
por: Schaffer, Andrea L., et al.
Publicado: (2022)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia
por: Bruno, Claudia, et al.
Publicado: (2020)

Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia
por: Brett, Jonathan, et al.
Publicado: (2018)

Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia
por: Havard, Alys, et al.
Publicado: (2021)

Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants
por: Morgan, Alice, et al.
Publicado: (2018)

Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients
por: Sotade, Oluwadamisola Temilade, et al.
Publicado: (2020)

Hospital characteristics associated with low-value care in public hospitals in New South Wales, Australia
por: Badgery-Parker, Tim, et al.
Publicado: (2020)

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions
por: Schaffer, Andrea L., et al.
Publicado: (2021)

Comparison of claims from high–drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis
por: Tadrous, Mina, et al.
Publicado: (2021)

Rates of Low-Value Service in Australian Public Hospitals and the Association With Patient Insurance Status
por: de Oliveira Costa, Juliana, et al.
Publicado: (2021)

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

Trends in self-poisoning and psychotropic drug use in people aged 5–19 years: a population-based retrospective cohort study in Australia
por: Cairns, Rose, et al.
Publicado: (2019)

Nexus of Cancer and Cardiovascular Disease for Australia’s First Peoples
por: Diaz, Abbey, et al.
Publicado: (2020)

Visualising linked health data to explore health events around preventable hospitalisations in NSW Australia
por: Falster, Michael O, et al.
Publicado: (2016)

Gazing through time and beyond the health sector: Insights from a system dynamics model of cardiovascular disease in Australia
por: Peng, Cindy Q., et al.
Publicado: (2021)

Patterns of immediate breast reconstruction in New South Wales, Australia: a population‐based study
por: Feng, Yingyu, et al.
Publicado: (2019)

The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia
por: Degenhardt, Louisa, et al.
Publicado: (2015)

Do hospitals influence geographic variation in admission for preventable hospitalisation? A data linkage study in New South Wales, Australia
por: Falster, Michael O, et al.
Publicado: (2019)

Social and geographical inequalities in school starting age in Australia: a population data linkage study
por: Hanly, Mark, et al.
Publicado: (2017)

Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia
por: Tran, Bich, et al.
Publicado: (2016)

Inequalities in pediatric avoidable hospitalizations between Aboriginal and non-Aboriginal children in Australia: a population data linkage study
por: Falster, Kathleen, et al.
Publicado: (2016)

In-hospital outcomes by insurance type among patients undergoing percutaneous coronary interventions for acute myocardial infarction in New South Wales public hospitals
por: de Oliveira Costa, Juliana, et al.
Publicado: (2023)

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: a prospective cohort investigation among adults aged 45 years and over in Australia
por: Du, Wei, et al.
Publicado: (2019)

Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future
por: Pearson, Sallie-Anne, et al.
Publicado: (2021)

"If you don't believe it, it won't help you": use of bush medicine in treating cancer among Aboriginal people in Western Australia
por: Shahid, Shaouli, et al.
Publicado: (2010)

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)
por: Daniels, Benjamin, et al.
Publicado: (2018)

Metastatic breast cancer incidence, site and survival in Australia, 2001–2016: a population-based health record linkage study protocol
por: Lord, Sarah J, et al.
Publicado: (2019)

Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage
por: Stavrou, Efty P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gve2iktpmvfeatkha36052eacj